Pfizer

Shares in US pharmaceutical company Pfizer are trading a little lower pre-market on Monday. Over recent weeks, the company has received a great deal of attention. This is due to the announcement that the COVID vaccine developed in a joint…
Read More

As illustrated in a Nature article published on Tuesday, scientists are puzzled by the preliminary results of covid tests. Given expectations and historic vaccination results, there appears to be something odd going on. And something…
Read More

Shares in US pharmaceutical company Pfizer have seen plenty of action over the last week. The company announced last week that itself and its German partner BioNTech had successfully proven their candidate COVID vaccine to be over 90%…
Read More

Another Drop for the Buck The US Index lost further momentum on Wednesday as it ended the session 0.10% down. More ground was given up as the greenback now trades precariously towards the 92 region. Sentiment shifted on positive …
Read More

Gold Gold has been firmly lower this week as the markets continued to digest the latest news within the COVID landscape. Pfizer and its German partner BioNTech announced that their vaccine has achieved more than 90% effectiveness in…
Read More

Shares in US pharmaceutical firm Pfizer are trading almost 1% higher pre-market on Wednesday. Pfizer and its German partner BioNTech have been working on a COVID vaccine. They have recently announced that they could be the first to…
Read More

Shares in US pharmaceutical company Pfizer are trading around 0.5% lower pre-market on Tuesday, extending the losses seen across recent days. Indeed, the sell-off comes despite news this week that Pfizer’s joint clinical trials with German…
Read More

Pfizer Revenues Expected to Slow in Q2 Pfizer reports the last quarter's results on Tuesday, July 28th at 6:45 EST (12:45 CET). A press conference will be held at 10:00 EST (16:00 CET) Top and bottom-line expectations: Earnings per…
Read More

Dollar Weak As Trump Argues Unemployment Benefits Renewal The dollar lost 0.25% on Monday against majors on increased risk appetite. Positive headlines around the EU’s recovery fund and the UK-Pfizer vaccination deal supported the…
Read More

Pfizer Gaps Higher Shares in Pfizer gapped up by almost 3% from Friday’s close at the US open yesterday. They are up another 0.54% pre-market on Tuesday as traders digest positive news regarding its vaccine development. On Monday, it…
Read More